blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3967690

EP3967690 - PYRROLE AMIDOPYRIDONE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  11.02.2022
Database last updated on 20.07.2024
FormerThe international publication has been made
Status updated on  28.09.2020
Most recent event   Tooltip28.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Shanghai Ringene BioPharma Co., Ltd.
Room 305, 3rd Floor
No.866 Halei Road, China (Shanghai)
Pilot Free Trade Zone, Pudong New Area
Shanghai 201203 / CN
[2022/11]
Inventor(s)01 / WAN, Huixin
No.888 Zhujiang Road
Juegang Town, Rudong County
Nantong, Jiangsu 226499 / CN
02 / PAN, Jianfeng
No.888 Zhujiang Road
Juegang Town, Rudong County
Nantong, Jiangsu 226499 / CN
03 / MA, Jingui
No.888 Zhujiang Road
Juegang Town, Rudong County
Nantong, Jiangsu 226499 / CN
 [2022/11]
Representative(s)Calysta NV
Lambroekstraat 5a
1831 Diegem / BE
[2022/11]
Application number, filing date20773591.112.03.2020
[2022/11]
WO2020CN78963
Priority number, dateCN20191020077217.03.2019         Original published format: CN201910200772
CN2019117357306.11.2019         Original published format: CN201911073573
[2022/11]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020187123
Date:24.09.2020
Language:ZH
[2020/39]
Type: A1 Application with search report 
No.:EP3967690
Date:16.03.2022
Language:EN
[2022/11]
Search report(s)International search report - published on:CN24.09.2020
(Supplementary) European search report - dispatched on:EP10.03.2023
ClassificationIPC:C07D471/04, A61K31/437, A61K31/538, A61K31/5386, A61K31/4523, A61K31/454, A61K31/496, A61P35/00, A61P35/02, A61P37/00, A61P29/00, A61P37/06, A61P11/02, A61P17/14, A61P25/28, A61P9/10, A61P11/06, A61P19/02, A61P17/00, A61P37/08, A61P1/16
[2022/11]
CPC:
A61P1/00 (EP,CN); C07D471/04 (EP,CN,KR,US); A61K31/437 (KR);
A61K31/4545 (KR); A61K31/538 (KR); A61P1/16 (EP,CN);
A61P1/18 (EP,CN); A61P11/00 (EP,CN); A61P11/02 (EP,CN);
A61P11/06 (EP,CN); A61P13/00 (EP); A61P13/02 (EP,CN);
A61P13/12 (EP,CN); A61P17/00 (EP,CN); A61P17/06 (EP,CN);
A61P17/14 (EP,CN); A61P19/02 (EP,CN); A61P19/06 (EP,CN);
A61P21/00 (EP,CN); A61P21/04 (EP,CN); A61P25/00 (EP,CN);
A61P25/16 (EP,CN); A61P25/28 (EP,CN); A61P29/00 (EP,CN);
A61P3/10 (EP,CN); A61P31/10 (EP,CN); A61P35/00 (EP,CN,KR);
A61P35/02 (EP,CN); A61P37/00 (EP); A61P37/02 (EP,CN);
A61P37/06 (EP,CN); A61P37/08 (EP,CN); A61P43/00 (EP);
A61P5/14 (EP,CN); A61P7/06 (EP,CN); A61P9/00 (EP);
A61P9/10 (EP,CN) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/11]
TitleGerman:PYRROLAMIDOPYRIDONVERBINDUNG, HERSTELLUNGSVERFAHREN DAFÜR UND VERWENDUNG DAVON[2022/11]
English:PYRROLE AMIDOPYRIDONE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF[2022/11]
French:COMPOSÉ DE PYRROLE AMIDOPYRIDONE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION[2022/11]
Entry into regional phase12.10.2021Translation filed 
12.10.2021National basic fee paid 
12.10.2021Search fee paid 
12.10.2021Designation fee(s) paid 
12.10.2021Examination fee paid 
Examination proceduredeletedDeletion: Application deemed to be withdrawn, date of legal effect  [2022/11]
12.10.2021Examination requested  [2022/11]
28.10.2021Despatch of communication that the application is deemed to be withdrawn, reason: filing fee / search fee not paid in time  [2022/11]
21.09.2023Amendment by applicant (claims and/or description)
Request for further processing for:The application is deemed to be withdrawn due to failure to file the translation
22.11.2021Request for further processing filed
22.11.2021Full payment received (date of receipt of payment)
Request granted
01.12.2021Decision despatched
Fees paidRenewal fee
02.03.2022Renewal fee patent year 03
23.03.2023Renewal fee patent year 04
27.03.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2015164480  (INCYTE CORP [US]) [X] 1 * pages 117-119; examples 1-4; claim 1 *;
 [E]WO2020092638  (NUVATION BIO INC [US]) [E] 1-3,12 * page 78; examples 268 , 269 ** Formula (Vc-7); page 48 *
International search[X]WO2014125408  (AURIGENE DISCOVERY TECH LTD [IN]) [X] 1-15 * Description, examples 5-9, 19, pages 3-21, Claims 1-21 *;
 [X]CN104136435  (ABBVIE INC) [X] 1-15 * Description, examples 69-73, 252-257, 269, 327, 337-339, Paragraphs 2-207, Claims 1-63 *;
 [X]US2015148372  (YUE EDDY W [US], et al) [X] 1-15* Abstract, Description, pages 12-27, Claims 1-42, examples 1-2, examples A1, B1, C1 *;
 [X]CN105026403  (ABBVIE INC) [X] 1, 11, 14 * Description, examples 58, 127, 194, 208, 239, 272 *;
 [X]CN105531273  (ABBVIE INC) [X] 1-15 * Description, examples 119-124, 133, 135, 143-148, 150-152, 157-158, 164, 187, Paragraphs 2-13, 169-231, Claims 1-39 *;
 [X]CN108069958  (KAIHUI SCIENCE & TECH DEVELOPMENT SHANGHAI CO LTD, et al) [X] 1-15 * Description, Paragraphs 288-317, 822-891, Claims 1-10 *;
 [X]CN109071534  (ABBVIE INC) [X] 1-15 * Description, examples 1, 3, 5, 28, 30-36, 38, 40-42, 49, 53-55, 57, 59-60, 63-75, 81-88, 90, 98-99, 104-108, 110-123, 126-129, Paragraphs 2-13, 126-195, Claims 1-37 *;
 [PX]CN110041253  (SHANGHAI HANSOH BIOMEDICAL CO LTD, et al) [PX] 1-15 * Description, Paragraphs 131-148, 1353-1424, examples 63-67 *;
 [PX]CN110143961  (JIANGSU PROVINCIAL ACAD TRADITIONAL CHINESE MED, et al) [PX] 1-15 * Description, examples 1-14, Paragraphs 6-85 *;
 [PX]CN110204543  (JIANGSU PROVINCIAL ACAD TRADITIONAL CHINESE MED, et al) [PX] 1-15 * Description, examples 1-10, Paragraphs 6-90 *;
 [PX]WO2020020288  (CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD [CN], et al) [PX] 1-15 * Description, examples 7, 10, 13-14, 22, Pages 1-13 *
by applicantWO2017177955
    - GREENWALD, R. B. et al., J. Med. Chem., (20000000), vol. A, B, page 475
    - Chiral Separations, Methods and Protocols, Methods in Molecular Biology, (20040000), vol. 243
    - A.M. STALCUP, Chiral Separations, Annu. Rev. Anal. Chem., (20100000), vol. 3, pages 341 - 63
    - VOGEL'S ENCYCLOPEDIA OF PRACTICAL ORGANIC CHEMISTRY 5.sup.TH ED., Longman Scientific and Technical Ltd., (19910000), pages 809 - 816
    - Heller, Acc. Chem. Res., (19900000), vol. 23, page 128
    - SAULNIER, M. G. et al., Bioorg. Med. Chem. Lett., (19940000), vol. 4, pages 1985 - 1990
 CN20191173573
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.